Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 25 results for "orchid chemicals and pharmaceuticals"

Orchid says it’s in talks for debt rejig

Drug firm Orchid Chemicals & Pharmaceuticals is in talks with banks to convert its rupee debt into dollar-denominated one. This is part of efforts to bring down the interest burden of the company, which will ultimately be beneficial to the bottom line, it ... Asian Age, 2 weeks ago
Orchid Chemicals gains on reports of debt rejig plan Business Standard, 2 weeks ago

5 images for orchid chemicals and pharmaceuticals

PR inside, 1 month ago
Business Standard, 1 month ago
Money Today, 3 months ago
India Infoline, 3 months ago
India Infoline, 3 months ago

Orchid Pharma to convert rupee term loans to foreign currency loans

Orchid Chemicals and Pharmaceuticals Ltd (OCPL) is planning to convert most its Rupee term loans of over Rs 1,500 crore into foreign currency loans, in order to save the higher interest paid at present. The company, which has a debt level of Rs 3165 ...
 Business Standard2 weeks ago Orchid Chemicals & Pharmaceuticals to hold AGM  Business Standard1 month ago

Orchid Pharma posts net loss at Rs 47.6 crore

Orchid Chemicals and Pharmaceuticals reported a standalone net loss of Rs 47.6 crore for the quarter ended June, against net loss of Rs 60.1 crore for the corresponding period in the previous financial year. Total operating income of the company was ...
 Business Standard1 month ago Orchid Chemicals Pharma Q1 net loss at Rs 47.56 cr  Moneycontrol.com1 month ago Orchid Chemicals & Pharmaceuticals Q1 net loss at Rs 48 cr  Business Standard1 month ago

Orchid Chemicals: Updates on outcome of AGM

Orchid Chemicals Pharmaceuticals Ltd has submitted to BSE a copy of Proceedings of the 22nd Annual General Meeting (AGM) of the Company held on September 15, 2015 along with a copy of Chairman's Speech.
 Money Control1 week ago Orchid Chemicals Pharmaceuticals AGM on Sept 15, 2015  Money Control1 month ago
Business Today India

Stocks that made news today: Sun Pharma, Vedanta and more

The benchmark Bombay Stock Exchange (BSE) Sensex closed over 258 points higher on a flurry of buying by investors amid a firming trend overseas ahead of the Fed's rate decision this week. The 30-share index rose 258.04 points, or 1 per cent, to ...
 Business Today India2 weeks ago

Investment Analysts Downgrades for September, 25th (MNRO, NBBC, NDRM, NMFC, OAK, OMN, PKG, PNFP, PPS, RCI)

Investment Analysts downgrades for Friday, September 25th: Monro Muffler Brake (NASDAQ:MNRO) was downgraded by analysts at Zacks from a buy rating to a hold rating. According to Zacks, Monro Muffler/Brake, Inc. is a chain of company-operated and ...
 SleekMoney1 week ago

Sensex inches higher

Posted by Equitymaster After trading on a firm note during the morning session of the day, the Indian equity markets have inched higher in the post noon trading session. Gains were led by stocks from pharma , banking and auto segments. The BSE-Sensex is ...
 Equitymaster.com2 weeks ago Sensex down over 500 points  Equitymaster.com4 weeks ago Indian markets plummet  Equitymaster.com4 weeks ago

Lupin jumps 8%, most in five years

Mumbai: Shares of Lupin Ltd on Thursday posted their biggest gain in five years after media reports suggesting that the company has secured key drug approvals from US Foods and Drugs Administration (FDA). The stock rose as much as 8.08%—the ...
 Livemint.com1 month ago

Forget big disappointments, small-caps surprise investors with up to 25-fold rise in Q1 earnings

As the April-June quarter corporate earnings season nears an end, there is clear disappointment among investors with respect to the earnings of large firms, which continued to post dismal set of numbers, but several small-cap firms emerged as a ...
 Firstpost.com1 month ago

Hospira Receives Average Rating of Hold from Brokerages (NYSE:HSP)

Shares of Hospira (NYSE:HSP) have earned an average recommendation of Hold from the eight brokerages that are covering the stock, Marketbeat reports . Six investment analysts have rated the stock with a hold rating and two have issued a buy rating ...
 WKRB News1 month ago Zacks Upgrades Hospira to Buy (HSP)  SleekMoney2 months ago Hospira Upgraded to Buy at Zacks (HSP)  WKRB News2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less